Tag Archives: pain

October, 2018

September, 2018

July, 2018

January, 2018

September, 2017

June, 2017

  • 9 June

    FDA Requests Removal of Opana ER for Risks Related to Abuse

    Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market. After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is …

May, 2017

November, 2016

April, 2016

  • 27 April

    FDA Approves Collegium’s Abuse-Deterrent Opioid Painkiller Xtampza ER

    CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza™ ER (oxycodone) extended-release (ER) capsules CII, a twice-daily, oxycodone medication for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for …